Clinical trial · Observational
Registry of Philadelphia-Negative Myeloproliferative Neoplasms
NCT02380378CI-TRIAL-00037900MPNunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was developed to document current diagnosis and treatment patterns, clinical outcomes, and health care resource use associated with Philadelphia-Negative Myeloproliferative Neoplasms, in the different risk classifications for each disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Diseases | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Myeloproliferative Neoplasms
- description
- Patients diagnosed with Myeloproliferative Neoplasms based on WHO 2008 criteria.
Primary outcomes (1)
- measure
- Registry of Philadelphia-Negative Myeloproliferative Neoplasms
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * diagnosis of (according to WHO 2008 criteria) Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis or Post-Polycythemia Vera/Post-Essential Thrombocythemia Myelofibrosis, Unclassifiable Myeloproliferative Neoplasm, Chronic Neutrophilic Leukemia, Chronic Eosinophilic Leukemia, Systemic Mastocytosis * diagnosis made since 2000 * patients who are being followed-up or not * signed informed consent form (for alive patients included in the prospective step of the study). Exclusion Criteria: * diagnosis of Chronic Myelogenous Leukemia * refusal to sign the informed consent form (for patients who are alive and will de included in the prospective step of the study.
References
Publications (0)
Data not yet available
No reference posted for this study.